Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe


EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive


Rare Conversations: Game changing opportunities for the R&D community to address existing challenges in rare diseases

Join the inaugural episode of the new Rare Conversations event series in 2022, aimed at powering the next decade of rare disease innovation in Europe. The […]

National Associations Council Summit 2022 | Biotechnology: Delivering Europe’s Industrial Strategy Across Sectors

EuropaBio’s National Associations Council (NAC) is a platform that brings together all EuropaBio’s National Associations and helps to ensure coordination of EuropaBio actions throughout Europe. The […]

EuropaBio 25th Anniversary | mRNA: A voyage of discovery and celebration

The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool.

HealthDay.si Conference 2021: Biotech Meets Digital

Biotechnology and digital are getting closer. Due to the high development of both segments, Slovenia has a great global opportunity in this convergent field of medicine. […]

EuropaBio Patient Bio-Forum | European Reference Networks: challenges, achievements and opportunities

EuropaBio, the European Association for Bioindustries, is proud to continue our platform for engaging patient and industry alike on pertinent healthcare debates: the Patient Bio-Forum. In […]

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?

European Biotech Week 2021

The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech […]

German Biotechnology Days

Germany’s largest biotech event, the German Biotechnology Days 2021 (Deutsche Biotechnologietage, DBT), will take place on 20th and 21st September in Stuttgart. With over 800 participants, […]

Treatment without borders: the EU case for equitable patient access to advanced therapies

The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important […]

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.

EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’


EU Healthcare Biotech Policy Priorities for SMEs

Join the EuropaBio Healthcare Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the ongoing […]

EuropaBio Patient BioForum: Advancing patient access to innovative treatments

2021 is set to be another landmark year in the area of health. It is hoped to not only relieve the burden of the COVID-19 pandemic […]

Taking health up a gear: value of advanced therapies

Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These […]

An EU Vision for Life Science and Biotechnology for a Healthy and Sustainable EU

With the ambitious target to cut greenhouse gas emissions by 55% compared to 1990 levels by 2030 and the EU Green Deal, the EU has set […]

Innovation for Health – Shaping the Future of Healthcare

On 15-16 April 2021, the 8th edition of Innovation for Health takes place as an online edition with hybrid aspect. Innovation for Health is the meeting place where […]

Immunology Virtual Partnering (Member Discount)

Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches […]

Oncology Virtual Partnering (Member Discount)

Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success – […]
Become a member